Showing 1 - 8 results of 8 for search 'Kristina W Thiel', query time: 0.03s Refine Results
  1. 1
    The Dawning of the Age of Personalized Medicine in Gynecologic Oncology

    The Dawning of the Age of Personalized Medicine in Gynecologic Oncology by Kimberly K. Leslie, Kristina W. Thiel, Doris M. Benbrook, David Mutch

    Published 2020-10-01
    Get full text
    Article
  2. 2
    Knockdown of MTDH sensitizes endometrial cancer cells to cell death induction by death receptor ligand TRAIL and HDAC inhibitor LBH589 co-treatment.

    Knockdown of MTDH sensitizes endometrial cancer cells to cell death induction by death receptor ligand TRAIL and HDAC inhibitor LBH589 co-treatment. by Xiangbing Meng, Pavla Brachova, Shujie Yang, Zhi Xiong, Yuping Zhang, Kristina W Thiel, Kimberly K Leslie

    Published 2011-01-01
    Get full text
    Article
  3. 3
    Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer.

    Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer. by Tamar Kavlashvili, Yichen Jia, Donghai Dai, Xiangbing Meng, Kristina W Thiel, Kimberly K Leslie, Shujie Yang

    Published 2016-01-01
    Get full text
    Article
  4. 4
    Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing

    Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing by Jianling Bi, Andreea M. Newtson, Yuping Zhang, Eric J. Devor, Megan I. Samuelson, Kristina W. Thiel, Kimberly K. Leslie

    Published 2021-06-01
    Get full text
    Article
  5. 5
    miR-888: A Novel Cancer-Testis Antigen that Targets the Progesterone Receptor in Endometrial Cancer

    miR-888: A Novel Cancer-Testis Antigen that Targets the Progesterone Receptor in Endometrial Cancer by Adriann M. Hovey, Eric J. Devor, Patrick J. Breheny, Sarah L. Mott, Donghai Dai, Kristina W. Thiel, Kimberly K. Leslie

    Published 2015-04-01
    Get full text
    Article
  6. 6
    Bacterial, Archaea, and Viral Transcripts (BAVT) Expression in Gynecological Cancers and Correlation with Regulatory Regions of the Genome

    Bacterial, Archaea, and Viral Transcripts (BAVT) Expression in Gynecological Cancers and Correlation with Regulatory Regions of the Genome by Jesus Gonzalez-Bosquet, Silvana Pedra-Nobre, Eric J. Devor, Kristina W. Thiel, Michael J. Goodheart, David P. Bender, Kimberly K. Leslie

    Published 2021-03-01
    Get full text
    Article
  7. 7
    Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy

    Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy by Jianling Bi, Garima Dixit, Yuping Zhang, Eric J. Devor, Haley A. Losh, Andreea M. Newtson, Kristen L. Coleman, Donna A. Santillan, Thorsten Maretzky, Kristina W. Thiel, Kimberly K. Leslie

    Published 2021-07-01
    Get full text
    Article
  8. 8
    Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line

    Characterization of HCI-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line by Craig M. Rush, Zannel Blanchard, Jacob T. Polaski, Kyle S. Osborne, Krystle Osby, Jeffery M. Vahrenkamp, Chieh-Hsiang Yang, David H. Lum, Christy R. Hagan, Kimberly K. Leslie, Miles A. Pufall, Kristina W. Thiel, Jason Gertz

    Published 2022-11-01
    Get full text
    Article

Search Tools: